Transforming growth factor β1 selectively inhibits the cyclic AMP- dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1)

Molecular Biology of the Cell

Volumn 11, Issue 3, 2000, Pages 1061-1076

  Depoortere, Fabienne ^a   Pirson, Isabelle ^a   Bartek, Jiri ^b   Dumont, Jacques E ^a   Roger, Pierre P ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIN DEPENDENT KINASE; CYCLINE; EPIDERMAL GROWTH FACTOR; NUCLEAR PROTEIN; PHORBOL ESTER; PROTEIN P27; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOG; EPITHELIUM CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SERUM; SIGNAL TRANSDUCTION; THYROID CELL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0034099227     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.3.1061     Document Type: Article

References (96)

1. Alexandrow, M.G., and Moses, H.L. (1995). Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Res. 55, 3928-3932.
2. Baptist, M., Dumont, J.E., and Roger, P.P. (1993). Demonstration of cell cycle kinetics in thyroid primary culture by immunostaining of proliferating cell nuclear antigen: differences in cyclic AMP-dependent and -independent mitogenic stimulations. J. Cell Sci. 705, 69-80.
3. Baptist, M., Dumont, J.E., and Roger, P.P. (1995). Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells. Exp. Cell Res. 221, 160-171.
4. Baptist, M., Lamy, F., Gannon, J., Hunt, T., Dumont, J.E., and Roger, P.P. (1996). Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AM P-dependent and -independent cell cycles. J. Cell Physiol. 166, 256-273.
5. Barnard, J. A., Lyons, R.M., and Moses, H.L. (1990). The cell biology of transforming growth factor beta. Biochim. Biophys. Acta 7032, 79-87.
6. Bartek, J., Bartkova, J., and Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8, 805-814.
7. Bartkova, J., Zemanova, M., and Bartek, J. (1996). Abundance and subcellular localization of cyclin D3 in human tumors. Int. J. Cancer 65, 323-327.
8. Beijersbergen, RL., Carlee, L., Kerkhoven, K.M., and Bernards, R. (1995). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353.
9. Blain, S.W., Montalvo, E., and Massague, J. (1997). Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cd k2 and cyclin D2-Cdk4. J. Biol. Chem. 272, 25863-25872.
10. Blaydes, J.P., Schlumberger, M., Wynford-Thomas, D., and Wyllie, F.S. (1995). Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation. Oncogene 10, 307-317.
11. Bouchard, C., Thieke, K., Maier, A.. Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinsky, P., Bartek, J and Eilers, M. (1999). Direct induction of cyclin D2 by myc contributes to cell cycle progression and sequestration of p27. EMBO J. 78, 5321-5333.
12. Chambard, J.C., and Pouyssegur, J. (1988). TGF-beta inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J. Cell Physiol. 135, 101-107.
13. Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M.F., Roberts, J.M., and Sherr, C.J. (1999). The p21(Cipl) and p27(Kip1) CDK inhibitors are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
14. Coats, S., Flanagan, W.M., Nourse, J., and Roberts, J.M. (1996). Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880.
15. Colletta, G., Cirafici, A.M., and Di Carlo, A. (1989). Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reductions of thyroid-specific differentiation markers. Cancer Res. 49, 3457-3462.
16. Connell-Crowley, J., Harper, J.W., and Goodrich, D.W. (1997). Cyclin D1/cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8, 287-301.
17. Contempre, B., Le Moine, O., Dumont, J.E., Denef, J.F., and Many, M.C. (1996). Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol. Cell Endocrinol. 124, 7-15.
18. Coulonval, K., Maenhaut, C., Dumont, J.E., and Lamy, F. (1997). Phosphorylation of the three Rb protein family members is a common step of the cAMP-, the growth factor, and the phorbol estermitogenic cascades but is not necessary for the hypertrophy induced by insulin. Exp. Cell Res. 233, 395-398.
19. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y., and Wang, X.F. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
20. Datto, M.B., Frederick, J.P., Pan, L., Borton, A.J., Zhuang, Y., and Wang, X.F. (1999). Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504.
21. Deleu, S., Pirson, I., Clermont, F., Nakamura, T., Dumont, J.E., and Maenhaut, C. (1999). Immediate early gene expression in dog thyrocytes in response to growth, proliferation and differentiation stimuli. J. Cell. Physiol. 187, 342-354.
22. Depoortere, F., Dumont, J.E., and Roger, P.P. (1996). Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J. Cell Sci. 309, 1759-1764.
23. Depoortere, F., Van Keymeulen, A., Lukas, J., Costagliola, S., Bartkova, J., Dumont, J.E., Bartek, J., Roger, P.P., and Dremier, S. (1998). A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140, 1427-1439.
24. Derynck, R. (1994). TGF-beta-receptor-mediated signaling. Trends Biochem. Sci. 79, 548-553.
25. Diehl, J.A., Cheng, M., Roussel, M.F., and Sherr, C.J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 72, 3499-3511.
26. Diehl, J.A., and Sherr, C.J. (1997). A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 27, 7362-7374.
27. Dong, F., Agrawal, D., Bagui, T., and Pledger, W.J. (1998a). Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. Mol. Biol. Cell 9, 2081-2092.
28. Dong, F., Cress, W.D.J., Agrawal, D., and Pledger, W.J. (1998b). The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 fibroblasts. J. Biol. Chem. 273, 6190-6195.
29. Ewen, M.E., Sluss, H.K., Whitehouse, L.L., and Livingston, D.M. (1993). TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74, 1009-1020.
30. Ewen, ME., Oliver, C.J., Sluss, H.K., Miller, S.J., and Peeper, D.S. (1995). p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. Genes Dev. 9, 204-217.
31. Florenes, V.A., Bhattacharya, N., Bani, MR., Ben-David, Y., Kerbel, R.S., and Slingerland, J.M. (1996). TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kipl. Genes Dev. 77, 3157-3167.
32. Grubeck-Loebenstein, B., Buchan, G., Sadeghi, R., Kissonerghis, M., Londei, M., Turner, M., Pirich, K., Roka, R., Niederle, B., and Kassal, H. (1989). Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J. Clin. Invest. 83, 764-770.
33. Gu, Y., Rosenblatt, J., and Morgan, D.O. (1992). Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 71, 3995-4005.
34. Hall, M., Bates, S., and Peters, G. (1995). Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11, 1581-1588.
35. Hannon, G.J., and Beach, D. (1994). p151NK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 377, 257-261.
36. Hengst, L., and Reed, S.I. (1998). Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227, 25-41.
37. Herrera, R.E., Makela, T.P., and Weinberg, R.A. (1996). TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7, 1335-1342.
38. Iavarone, A., and Massague, J. (1997). Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387, 417-422.
39. Kato, J.Y., Matsuoka, M., Polyak, K., Massague, J., and Sherr, C.J. (1994). Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496.
40. Kelly, B.L., Wolfe, K.G., and Roberts, J.M. (1998). Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 95, 2535-2540.
41. Kitagawa, M., et al. (1996). The consensus motif for phosphorylation by cyclin Dl-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 75, 7060-7069.
42. Ko, T.C., Sheng, H.M., Reisman, D., Thompson, E.A., and Beauchamp, R.D. (1995). Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 70, 177-184.
43. Kretzschmar, M., Doody, J., Timokhina, I., and Massague, J. (1999). A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13, 804-816.
44. L'Allemain, G., Lavoie, J.N., Rivard, N., Baldin, V., and Pouyssegur, J. (1997). Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 74, 1981-1990.
45. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A., and Harlow, E. (1997). New functional activities for the p21 family of CDK inhibitors. Genes Dev. 77, 847-862.
46. Laiho, M., DeCaprio, J.A., Ludlow, J.W., Livingston, D.M., and Massague, J. (1990). Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175-185.
47. Lamy, F., Wilkin, F., Baptist, M., Posada, J., Roger, P.P., and Dumont, J.E. (1993). Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenics pathway. J. Biol. Chem. 268, 8398-8401.
48. Liu, F., and Massague, J. (1997). Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev. 11, 3157-3167.
49. Logan, A., Smith, C., Becks, G.P., Gonzalez, A.M., Phillips, I.D., and Hill, D.J. (1994). Enhanced expression of transforming growth factor-beta 1 during thyroid hyperplasia in rats. J. Endocrinol. 141, 45-57.
50. Lukas, J., Bartkova, J., and Bartek, J. (1996). Convergence of mitogenic signaling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 76, 6917-6925.
51. Lukas, J., Herzinger, T., Hansen, K., Moroni, M.C., Resnitzky, D., Helin, K., Reed, S.I., and Bartek, J. (1997). Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 77, 1479-1492.
52. Lundberg, A.S., and Weinberg, R.A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753-761.
53. Lyons, R.M., and Moses, H.L. (1990). Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187, 467-473.
54. Mahony, D., Parry, D.A., and Lees, E. (1998). Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 76, 603-611.
55. Massague, J. (1998). TGP-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
56. Moore, J.D., Yang, J., Truant, R., and Kornbluth, S. (1999). Nuclear import of Cdk/cyclin complexes: identification of distinct mecha-nisms for import of Cdk2/cyclin E and Cdc2/cyclin B1. J. Cell Biol. 744, 213-224.
57. Nakao, A., et al. (1997). TGF-beta receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 76, 5353-5362.
58. Nourse, J., Firpo, E., Flanagan, W.M., Coats, S., Polyak, K., Lee, M.H., Massague, J., Crabtree, G.R., and Roberts, J.M. (1994). Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
59. Ohtani, K., DeGregori, J., and Nevins, J.R. (1995). Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92, 12146-12150.
60. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685.
61. Cipt. EMBO J. 18, 5310-5320.
62. Pietenpol, J.A., Holt, J.T., Stein, R.W., and Moses, H.L. (1990). Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87, 3758-3762.
63. Pirson, I., Coulonval, K., Lamy, F., and Dumont, J.E. (1996). c-Myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes. J. Cell Physiol. 168, 59-70.
64. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M., and Koff, A. (1994). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
65. Polyak, K. (1996). Negative regulation of cell growth by TGF beta. Biochim. Biophys. Acta 1242, 185-199.
66. Poon, R.Y., Toyoshima, H., and Hunter, T. (1995). Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6, 1197-1213.
67. Resnitzky, D., Hengst, L., and Reed, S.I. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in Gl by p27Kip1. Mol. Cell. Biol. 15, 4347-4352.
68. Reuse, S., Pirson, I., and Dumont, J.E. (1991). Differential regulation of protooncogenes c-jun and jun D expressions by protein tyrosine kinase, protein kinase C, and cyclic-AMP mitogenic pathways in dog primary thyrocytes: TSH and cyclic-AMP induce proliferation but downregulate C-jun expression. Exp. Cell Res. 796, 210-215.
69. Reynisdottir, I., Polyak, K., lavarone, A., and Massague, J. (1995). Kip/Cip and lnk4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831-1845.
70. Reynisdottir, I., and Massague, J. (1997). The subcellular locations of pl5(lnk4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11, 492-503.
71. Roberts, A.B., Anzano, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., and Sporn, M.B. (1985). Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82, 119-123.
72. Roger, P.P., Servais, P., and Dumont, J.E. (1987a). Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator. Exp. Cell Res. 772, 282-292.
73. Roger, P.P., Servais, P., and Dumont, J.E. (1987b). Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. J. Cell Physiol. 130, 58-67.
74. Roger, P.P., Baptist, M., and Dumont, J.E. (1992). A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J. Cell Biol. 777, 383-393.
75. Roger, P.P. (1996). Thyrotropin-dependent transforming growth factor beta expression in thyroid gland |comment|. Eur. J. Endocrinol. 734, 269-271.
76. Roger, P.P., Demartin, S., and Dumont, J.E. (1999). Nature of the critical labile event that controls RB phosphorylation in the cyclic AMP-dependent cell cycle of thyrocytes in primary culture. Exp. Cell Res. 252, 492-498.
77. Russo, A.A., long, L., Lee, J.O., Jeffrey, P.D., and Pavletich, N.P. (1998). Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16INIK4a. Nature 395, 237-243.
78. Sandhu, C., Garbe, J., Bhattacharya, N., Daksis, J., Pan, C.H., Yaswen, P., Koh, J., Slingerland, J.M., and Stampfer, M.R. (1997). Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 77, 2458-2467.
79. Schwarz, J.K., Bassing, C.H., Kovesdi, L, Datto, M.B., Blazing, M., George, S., Wang, X.F., and Nevins, J.R. (1995). Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92, 483-487.
80. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
81. Smith, P., Williams, E.D., and Wynford-Thomas, D. (1987). In vitro demonstration of a TSH-specific growth desensitizing mechanism in rat thyroid epithelium. Mol. Cell Endocrinol. 57, 51-58.
82. Soos, T.J., Kiyokawa, H., Yan, J.S., Rubin, M.S., Giordano, A., De-Blasio, A., Bottega, S., Wong, B., Mendelsohn, J., and Koff, A. (1996). Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7, 135-146.
83. Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., and Eilers, M. (1995). Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J. 24, 4814-4826.
84. Tassan, J.P., Schultz, S.J., Bartek, J., and Nigg, E.A. (1994). Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 227, 467-478.
85. Taton, M., Lamy, F., Roger, P.P., and Dumont, J.E. (1993). General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol. Cell Endocrinol. 95, 13-21.
86. Tsubari, M., Taipale, J., Tiihonen, E., Keski-Oja, J., and Laiho, M. (1999). Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol. Cell. Biol. 29, 3654-3663.
87. Tsushima, T., Arai, M., Saji, M., Ohba, Y., Murakami, H., Ohmura, E., Sato, K., and Shizume, K. (1988). Effects of transforming growth factor-beta on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture. Endocrinology 223, 1187-1194.
88. Van Keymeulen, A., Bartek, J., Dumont, J.E., and Roger, P.P. (1999). Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 18, 7351-7359.
89. Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D., and Amati, B. (1996). Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 35, 6595-6604.
90. Wang, Z., Sicinski, P., Weinberg, R.A., Zhang, Y., and Ravid, K. (1996). Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. Genomics 35, 156-163.
91. Ward, A.C., Csar, X.F., Hoffmann, B.W., and Hamilton, J.A. (1996). Cyclic AMP inhibits expression of D-type cyclins and cdk4 and induces p27Kip1 in G-CSF-treated NFS-60 cells. Biochem. Biophys. Res. Commun. 224, 10-16.
92. 1 arrest pathway. Mol. Cell. Biol. 19, 5913-5922.
93. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
94. Wynford-Thomas, D., Stringer, B.M., Harach, H.R., and Williams, E.D. (1983). Control of growth in the rat thyroid - an example of specific desensitization to trophic hormone stimulation. Experientia 39, 421-423.
95. Zerfass-Thome, K., Schulze, A., Zwerschke, W., Vogt, B., Helin, K., Bartek, J., Henglein, B., and Jansen-Durr, P. (1997). p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17, 407-415.
96. Zhang, Y., Feng, X.H., and Derynck, R. (1998). Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394, 909-913.